Mayoly China expands its GI product portfolio — Forlax® Lactulose Oral Solution was officially launched on JD Self-operated platform on September 30 and available for consumers. The launch further enriches Forlax’s product lineup in intestinal health, delivering more accessible and convenient intestinal health solutions for patients and consumers.

As a well-established brand with years of experience in constipation management in China, Forlax® boasts solid clinical evidence and strong market reputation. The newly launched Forlax® Lactulose Oral Solution works via the mild osmotic mechanism of lactulose to treat chronic functional constipation. It is suitable for a wide range of populations and meets diverse usage needs across multiple scenarios.

JD Self-operated is a leading online pharmaceutical channel in China, featuring guaranteed product authenticity and efficient delivery. This collaboration leverages the mature online retail capabilities of JD Health to rapidly expand market reach for the new Forlax product, enabling consumers to purchase genuine products without leaving home. Meanwhile, the launch of this online channel complements existing offline channels and builds an integrated omnichannel commercial layout combining online and offline sales.

No comments yet, be the first to comment.

Lascia un commento